$SNPS

Ghazi Sassine sold $6.7M of SNPS

Ghazi Sassine (PRESIDENT AND CEO) sold 14,603 shares of SYNOPSYS INC (SNPS) at $458.96 ($6.70M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ghazi Sassine
Published Jun 16, 2026, 8:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SNPS
Neutral
high confidence
Mentioned
$SNPS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The disclosure can slightly influence sentiment, but it does not introduce new fundamentals; the pre-arranged nature lowers interpretability as a near-term negative catalyst.

02

Market read

A single-day CEO sale (~$6.7M) is disclosed; likely modest sentiment impact only.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or regulatory/product news, the signal is typically weak.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-16 for a sale executed 2026-06-15

Background

The article is an SEC Form 4 insider transaction: CEO Ghazi Sassine sold shares of Synopsys on 10b5-1.

Company-level read

Ticker impact

$SNPSNeutralHigh confidence
Context

Synopsys CEO Ghazi Sassine sold 14,603 shares for about $6.7M under a pre-arranged 10b5-1 plan disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect should be modest and sentiment-driven rather than catalyst-driven.

Evidence & confidence

The filing is a routine Form 4 open-market sale with an explicitly pre-arranged 10b5-1 plan, providing no new operating or financial information.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Synopsys

    Company whose CEO insider sale is disclosed via SEC Form 4.

  • Ghazi Sassine

    President and CEO who sold 14,603 shares.

  • 10b5-1 plan

    Pre-arranged plan that reduces the inference of new private information.

Related articles

$SNPSMedAI 8/10

Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary.

Synopsys raised its full-year fiscal 2026 revenue guidance midpoint to $9.665 billion and lifted non-GAAP EPS guidance to $14.76 at the midpoint, driven by strong first-half performance, accelerating Ansys integration synergies, and expanded operating margins. For Q3 fiscal 2026, management guided revenue of $2.41–$2.46 billion and non-GAAP EPS of $3.63–$3.69.

$SNPSMed

Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed

Synopsys' valuation remains difficult to assess on its headline numbers. The forward GAAP price-to-earnings (P/E) makes it look extraordinarily expensive, while the price-to-sales (P/S) ratio does the opposite. The reason is the $35 billion Ansys acquisition. The forward P/E of 138.39x sits 91% above its 5-year average of 72.47x. The Ansys acquisition is holding down the reported earnings, making the stock look inflated.

$SNPSMed

Synopsys Doubles Down on AI Chip Design With Microsoft and AMD. How to Play SNPS Stock Here.

Synopsys (SNPS) shares rose more than 4% after the company unveiled autonomous AI workflows for chip design at the 2026 DAC Chips to Systems Conference. Synopsys said the workflows, built with Microsoft (MSFT) and evaluated by AMD (AMD), can cut debug cycles by 25% to 40%. SNPS reported fiscal Q2 2026 revenue of $2.27B and raised FY2026 outlook to about $9.665B revenue and $14.76 EPS.

$SNPSMed

Synopsys Certifies Its Chip Design Tools on Intel’s 14A Node

Synopsys said it certified its chip design toolchain for Intel’s (INTC) 14A process node, announced July 27, 2026. The certification covers digital and analog implementation, signoff, multiphysics analysis, and node-tuned interface and foundation IP, plus updates to its 3DIC Compiler for Intel packaging. Intel reported 14A foundry revenue not broken out, with $5.8B foundry revenue and a $2.09B operating loss in Q2 2026.

$SNPSMed

Synopsys Should Benefit No Matter Who Wins The AI Race. Here’s What Explains Its Poor Stock Performance.

Synopsys (SNPS) is trading at a forward GAAP P/E of 157.39x, 119% above its 5-year average, which the article attributes to earnings pressure and higher costs tied to its Ansys acquisition. It cites Q2 FY2026 revenue of $2.276B, including $652M from Ansys, and GAAP EPS of $0.09. FY2026 guidance: revenue $9.625B-$9.705B, non-GAAP EPS $14.72-$14.80. Piper Sandler raised its target to $550.